Madelon van Agteren

Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution

Michiel G.H. Betjes, Madelon van Agteren · Nephrology Dialysis Transplantation · 2004 · 215 citations · Full text

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

Dennis A. Hesselink, Ron H. N. van Schaik, Madelon van Agteren et al. · Pharmacogenetics and Genomics · 2008 · 126 citations

UGT1A9 -275T>A/-2152C>T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus-Treated Kidney Transplant Patients

Ron H. N. van Schaik, Madelon van Agteren, Johan W. de Fijter et al. · Clinical Pharmacology & Therapeutics · 2009 · 118 citations

ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption

Annelies E. de Weerd, Madelon van Agteren, Frank W.G. Leebeek et al. · Transplant International · 2014 · 51 citations

AcylMPAG Plasma Concentrations and Mycophenolic Acid-Related Side Effects in Patients Undergoing Renal Transplantation Are Not Related to the UGT2B7-840G>A Gene Polymorphism

Madelon van Agteren, Victor W. Armstrong, Ron H. N. van Schaik et al. · Therapeutic Drug Monitoring · 2008 · 45 citations